Sanofi (SNYNF) Share-based Compensation (2009 - 2023)
Sanofi (SNYNF) posted Share-based Compensation of $2.1 million for Q4 2021, down 99.96% sequentially from $5.2 billion in Q2 2021, and up 7.94% YoY from $1.9 million in Q4 2020.
Sanofi (SNYNF) Share-based Compensation (2009 - 2023) Analysis & Trends
Sanofi has reported Share-based Compensation for 6 years, with the latest figure at $2.1 million in Q4 2021.
- Quarterly Share-based Compensation rose 7.94% year-over-year to $2.1 million in Q4 2021, while the trailing twelve-month figure through Jun 2021 was $5.2 billion (changed N/A YoY) and the FY2025 annual result came in at $364.3 million, up 22.65% from the prior year.
- Share-based Compensation eased to $2.1 million in Q4 2021 per SNYNF's latest filing, from $5.2 billion in the prior quarter.
- Over five years, Share-based Compensation peaked at $5.2 billion in Q2 2021 and troughed at $1.5 million in Q4 2019.
- A 3-year average of $1.3 billion and a median of $2.0 million in 2020 frame the typical range for Share-based Compensation.
- The sharpest annual moves came in 2020 and 2021: Share-based Compensation grew 23.1% in 2020, then rose 7.94% in 2021.
- Over 3 years, Share-based Compensation stood at $1.5 million in 2019, then grew by 23.1% to $1.9 million in 2020, then advanced by 7.94% to $2.1 million in 2021.
- According to Business Quant data, Share-based Compensation over the past three periods registered $2.1 million, $5.2 billion, and $1.9 million for Q4 2021, Q2 2021, and Q4 2020 respectively.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 304.49 Mn |
| Dec 31, 2023 | 304.49 Mn |
| Dec 31, 2021 | 2.06 Mn |
| Dec 31, 2021 | 2.06 Mn |
| Jun 30, 2021 | 5.17 Bn |
| Jun 30, 2021 | 5.17 Bn |
| Dec 31, 2020 | 1.91 Mn |
| Dec 31, 2020 | 1.91 Mn |
| Dec 31, 2019 | 1.55 Mn |
| Dec 31, 2019 | 1.55 Mn |
| Dec 31, 2015 | 3.08 Bn |
| Dec 31, 2015 | 3.08 Bn |
| Dec 31, 2012 | 2.80 Bn |
| Dec 31, 2012 | 2.80 Bn |
| Dec 31, 2009 | 2.50 Bn |
| Dec 31, 2009 | 2.50 Bn |